FORT WORTH, Texas, March 31 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. announced today that its subsidiary Wound Care Innovations, LLC launched a new section for patients on their CellerateRx(R) web site. The new area of the web site is intended to help diabetic patients learn how the advanced wound care collagen product, CellerateRx(R), may help them. It focuses on information for home diabetic patients that have acute or chronic diabetic wounds and are looking for a safe, effective, easy to use product. It provides easy to understand product information and application guidelines. It also has an area to print product information to take to a healthcare provider.
Wound Care Innovations also announced its first newsletter, Activated Collagen(TM) News. This reoccurring newsletter features up to date information about diabetes and other wound types, as well as a segment "Meet the Wound Care Expert." One area will focus on patient specific experiences with CellerateRx(R). This issue features a patient who had a non-healing wound for ten (10) years prior to using CellerateRx(R). The newsletter can be found on the www.celleraterx.com web site under the About Us Section.
About Wound Care Innovations, LLC
About Wound Management Technologies, Inc.
Safe Harbor Statement:
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
Shareholder Relations-Communications -561-515-6035
Wound Management Technologies, Inc.
